More

    DCGI approval for Bharat Biotech’s nasal booster dose trials

    HealthCOVID-19DCGI approval for Bharat Biotech’s nasal booster dose trials
    - Advertisment -

    DCGI approval for Bharat Biotech’s nasal booster dose trials

    The producer of India’s indigenous vaccine, Covaxin, will now be able to conduct trials of its nasal vaccine as a booster dose at nine locations in the country.

    The Drug Controller General of India today gave its approval to Indian biotechnology-pharma company, Bharat Biotech, to conduct Phase-III clinical trials of a nasal vaccine it has developed. The trials of the intranasal booster dose will be conducted on people who have received both doses of Bharat Biotech’s Covaxin.

    Covaxin producer will now be able to conduct trials of its nasal vaccine as a booster dose at nine locations in the country.

    An intranasal vaccine has logistical advantages and will be easier to administer in mass vaccination drives. The company claims that the BBV154 vaccine stimulates a broad immune response, especially at the site of infection (in the nasal mucosa that lines the nasal cavity) – essential for blocking both infection and transmission of COVID-19.

    - Advertisement -

    Besides ease of administration – as it does not require trained health care workers, the nasal vaccine also eliminates risks of injuries and infections that might be associated with a needle administered jab. It can elicit a high degree of compliance, especially as it suits children and adults.

    The non-invasive and needle-free nasal route has excellent potential for vaccination due to the organised immune systems of the nasal mucosa.

    Biotechnology feat

    The biotechnology company has applied to the Drug Controller General of India for approval for phase-III trials of the BBV154 vaccine in December 2021.

    If given the green signal following the trials, Bharat Biotech claims it will be able to undertake large-scale to meet global demands.

    The attenuated avirulant vaccine comes from a modified chimpanzee adenovirus. (This is a harmless, weakened adenovirus that usually causes the common cold in chimpanzees.) In this respect, the operative biologicals of this vaccine are somewhat like the AstraZeneca vaccine that also uses a chimpanzee adenovirus vaccine vector that has been genetically changed to stop it from adversely affecting humans.

    According to the company, mice, hamsters and macaques immunized with a single dose of the vaccine “conferred superior protection against SARS-CoV-2 challenge”.

    It claims that intranasal immunization “can create an immune response in the nose, which is the point of entry for the virus—thereby protecting against disease, infection, and transmission.”

    - Advertisement -

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Latest news

    South Asian Youth Urged to Become Climate Influencers as Video Contest Deadline Nears

    With only twelve days remaining until the final submission deadline on November 30, 2026, young content creators, environmental enthusiasts, and aspiring social media influencers across SouthAsia are being called upon to turn their smartphones into instruments of regional change.

    Sri Lanka’s Wild Elephants Carry Kilos of Metal Fragments Amid Escalating Conflict

    Unless Sri Lanka dismantles illegal weapon networks, halts the encroachment of migratory corridors, and supports rural farmers with non-lethal crop protection, the island’s surviving elephants will continue to bear the heavy, metallic scars of a broken coexistence.

    Medical Bills Push 10.8 Million Bangladeshis into Poverty as Out-of-Pocket Costs Soar

    Out-of-pocket healthcare spending in Bangladesh has emerged as a major driver of impoverishment, according to a recent government study that paints a stark picture of financial vulnerability in one of South Asia’s most most densely populated nations.

    Pakistani Farmers Take German Industrial Giants to Court Over 2022 Climate Calamity

    The lawsuit challenges the geographic insulation historically enjoyed by major industrial polluters, demonstrating that the fight for climate liability now crosses borders and continents.
    - Advertisement -

    Sri Lanka Faces Mounting Healthcare Crisis as Rapidly Ageing Population Outpaces Support Systems

    Meeting this unprecedented transition requires moving geriatric medicine from isolated academic hospitals directly into routine community care.

    Taliban Seek Senior Religious Title for Supreme Leader Amid Kabul University Gathering

    For the academics compelled to participate, however, the immediate reality is less about theological nomenclature than personal survival. Under a rule of law defined exclusively by unchallengeable executive decrees, even a routine conference survey has become a loyalty test with far-reaching consequences for Afghanistan’s remaining intellectual community.

    Must read

    South Asian Youth Urged to Become Climate Influencers as Video Contest Deadline Nears

    With only twelve days remaining until the final submission deadline on November 30, 2026, young content creators, environmental enthusiasts, and aspiring social media influencers across SouthAsia are being called upon to turn their smartphones into instruments of regional change.

    Sri Lanka’s Wild Elephants Carry Kilos of Metal Fragments Amid Escalating Conflict

    Unless Sri Lanka dismantles illegal weapon networks, halts the encroachment of migratory corridors, and supports rural farmers with non-lethal crop protection, the island’s surviving elephants will continue to bear the heavy, metallic scars of a broken coexistence.
    - Advertisement -

    More from the sectionRELATED
    Recommended to you